Published in Ann Oncol on July 28, 2007
Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol (2011) 2.06
Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer. Gastric Cancer (2011) 1.45
Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. Br J Cancer (2010) 1.21
Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer. Pharmacogenomics J (2010) 1.18
Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians. Pharmacogenomics J (2013) 1.07
The Role of Surgery for Asymptomatic Primary Tumors in Unresectable Stage IV Colorectal Cancer. Ann Coloproctol (2013) 0.95
Evaluation of prognostic factors in liver-limited metastatic colorectal cancer: a preplanned analysis of the FIRE-1 trial. Br J Cancer (2013) 0.84
EGFR L2 domain mutation is not correlated with resistance to cetuximab in metastatic colorectal cancer patients. J Cancer Res Clin Oncol (2013) 0.82
Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer. Oncotarget (2016) 0.80
A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer. Br J Cancer (2015) 0.80
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy. Br J Cancer (2008) 0.80
How to select the optimal treatment for first line metastatic colorectal cancer. World J Gastroenterol (2014) 0.78
Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups. Lung Cancer (2015) 0.75
Systematic analysis of design and stratification for phase III trials in first-line advanced non-small cell lung cancer. Thorac Cancer (2015) 0.75
Pattern and Dynamics of Distant Metastases in Metastatic Colorectal Cancer. Visc Med (2017) 0.75
Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy? Support Care Cancer (2009) 0.75
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med (2001) 13.75
Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med (1997) 9.99
Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol (2012) 5.32
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol (2002) 3.91
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst (1999) 3.46
Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ (1995) 3.30
Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol (2005) 2.66
Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64
Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. N Engl J Med (2001) 2.09
Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum (1998) 2.09
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer (1999) 1.97
Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol (1994) 1.96
Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg (1990) 1.93
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol (2009) 1.93
Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg (2008) 1.87
Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum (1993) 1.87
Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer. Ann Oncol (2009) 1.77
Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut (2005) 1.75
Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst (1995) 1.74
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. Ann Oncol (2005) 1.71
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol (2005) 1.67
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). Eur J Cancer (2002) 1.66
Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res (1999) 1.63
A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol (2001) 1.61
Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol (1996) 1.59
Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial. Br J Surg (2013) 1.56
Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion. Eur J Clin Pharmacol (2008) 1.56
Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer. Br J Surg (2006) 1.54
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res (2003) 1.54
Anorectal malignant melanoma in Sweden. Report of 49 patients. Dis Colon Rectum (1990) 1.50
Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann Oncol (2004) 1.49
A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol (2001) 1.46
Relationship between age and survival in cancer of the colon and rectum with special reference to patients less than 40 years of age. Br J Surg (1990) 1.45
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. Ann Oncol (2007) 1.44
Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer (1999) 1.44
Heparan sulfate proteoglycan of cultured cells: demonstration of a lipid- and a matrix-associated form. Biochem Biophys Res Commun (1981) 1.44
Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol (2001) 1.42
On prejudice and facts and choices. Ann Oncol (2006) 1.42
Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. Br J Cancer (1992) 1.39
Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg (2012) 1.37
A systematic overview of chemotherapy effects in breast cancer. Acta Oncol (2001) 1.36
Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer (1999) 1.36
Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst (1993) 1.34
The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy. Ann Oncol (2011) 1.33
Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg (2010) 1.31
Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Ann Oncol (2008) 1.29
Maternal and perinatal risk factors for childhood brain tumors (Sweden). Cancer Causes Control (1996) 1.24
Population-based study of the contribution of weather to hip fracture seasonality. Am J Epidemiol (1995) 1.23
Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol (2005) 1.21
Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol (1999) 1.20
Local recurrences after surgical treatment for rectal carcinoma. Acta Chir Scand (1984) 1.19
Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status. Br J Cancer (2009) 1.18
Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer (2004) 1.17
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer. Br J Cancer (2011) 1.16
Effect of a platelet endoglycosidase on cell surface associated heparan sulphate of human culturei endothelial and glial cells. Thromb Res (1977) 1.15
Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group. Eur J Cancer (2011) 1.15
Composition and distribution of glycosaminoglycans in cultures of human normal and malignant glial cells. Biochem J (1978) 1.15
Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial. Ann Surg (1999) 1.15
Improved survival of patients with cancers of the colon and rectum? J Natl Cancer Inst (1988) 1.15
Demonstration of an extracellular matrix in multicellular tumor spheroids. Cancer Res (1984) 1.14
Prognostic predictors in colorectal cancer. Dis Colon Rectum (1994) 1.13
Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism? J Natl Cancer Inst (1999) 1.13
Predicting anxiety and depression among cancer patients: a clinical model. Eur J Cancer (2001) 1.13
Development of microsatellite markers in Fragaria, their use in genetic diversity analysis, and their potential for genetic linkage mapping. Genome (2004) 1.12
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial. Ann Oncol (2007) 1.12
Binding of heparin on the surface of cultured human endothelial cells. Thromb Res (1978) 1.12
Changing strategy for rectal cancer is associated with improved outcome. Br J Surg (1999) 1.11
The role of the general practitioner in cancer care and the effect of an extended information routine. Scand J Prim Health Care (2000) 1.11
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. Br J Cancer (2009) 1.11
The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study. Cancer (1990) 1.10
Incidence of anal epidermoid carcinoma in Sweden 1970-1984. Acta Chir Scand (1989) 1.10
Improved survival in patients with rectal cancer: a population-based register study. Br J Surg (1998) 1.10
A chondroitin sulphate proteoglycan from human cultured glial cells aggregates with hyaluronic acid. Biochem Biophys Res Commun (1978) 1.09
The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy. Cancer (1999) 1.09
The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study. Eur J Surg Oncol (2004) 1.09
Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg (2006) 1.08
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study). Ann Oncol (2014) 1.07
Complications after double and single stapling in rectal surgery. Eur J Surg (1991) 1.07
Influence of 5-fluorouracil and folinic acid on colonic healing: an experimental study in the rat. Br J Surg (1992) 1.07
Comparative treatment planning between proton and x-ray therapy in esophageal cancer. Int J Radiat Oncol Biol Phys (1998) 1.07
The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer. Phys Med Biol (2005) 1.07
Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematol Oncol (1990) 1.05
Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease. Cancer Epidemiol Biomarkers Prev (2000) 1.05
Lymphoma incidence in a Swedish county during 1969-1987. Acta Oncol (1992) 1.05
Implementation of pencil kernel and depth penetration algorithms for treatment planning of proton beams. Phys Med Biol (2000) 1.05
Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer (2005) 1.04
Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients. Int J Cancer (1994) 1.04
Treatment of local recurrences of rectal carcinoma. Radiother Oncol (1995) 1.04
Group rehabilitation for cancer patients: satisfaction and perceived benefits. Patient Educ Couns (2000) 1.03
Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control (1998) 1.03
Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival. Clin Cancer Res (2000) 1.03
A systematic overview of chemotherapy effects in non-small cell lung cancer. Acta Oncol (2001) 1.02
Determinants of prognosis in advanced colorectal cancer. Eur J Cancer (1991) 1.02